- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 7/56 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
Patent holdings for IPC class C07K 7/56
Total number of patents in this class: 525
10-year publication summary
|
40
|
39
|
45
|
40
|
38
|
43
|
27
|
34
|
41
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4872 |
43 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 67 |
38 |
| Palatin Technologies, Inc. | 73 |
14 |
| Protagonist Therapeutics, Inc. | 138 |
11 |
| Aileron Therapeutics, Inc. | 80 |
10 |
| Zealand Pharma A/S | 251 |
9 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
8 |
| NovoBiotic Pharmaceuticals, LLC | 21 |
7 |
| Polyphor Ltd. | 18 |
7 |
| Provincial Health Services Authority | 185 |
7 |
| The University of Tokyo | 4162 |
7 |
| Xellia Pharmaceuticals ApS | 91 |
7 |
| Bicyclerd Limited | 142 |
7 |
| President and Fellows of Harvard College | 5957 |
6 |
| Novartis AG | 10882 |
5 |
| The Regents of the University of California | 19859 |
5 |
| The Texas a & M University System | 1683 |
5 |
| Universitaet Zuerich | 33 |
5 |
| The University of British Columbia | 1498 |
5 |
| Shanghai Shengdi Pharmaceutical Co., Ltd | 118 |
5 |
| Other owners | 314 |